| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.79B | 47.25B | 49.14B | 49.05B | 44.81B | 39.35B |
| Gross Profit | 13.42B | 14.01B | 13.17B | 12.73B | 10.41B | 9.89B |
| EBITDA | 4.88B | 5.14B | 4.90B | 5.15B | 2.81B | 3.13B |
| Net Income | 2.62B | 2.83B | 2.46B | 2.55B | 1.17B | 1.15B |
Balance Sheet | ||||||
| Total Assets | 70.79B | 70.13B | 70.17B | 72.39B | 69.56B | 68.42B |
| Cash, Cash Equivalents and Short-Term Investments | 8.68B | 8.75B | 8.93B | 8.78B | 7.01B | 6.79B |
| Total Debt | 11.25B | 10.67B | 10.69B | 13.73B | 15.28B | 16.71B |
| Total Liabilities | 30.96B | 28.19B | 29.60B | 34.09B | 34.48B | 34.42B |
| Stockholders Equity | 39.05B | 41.11B | 39.84B | 37.62B | 34.46B | 33.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.46B | 3.87B | 3.46B | 1.62B | 1.06B |
| Operating Cash Flow | 0.00 | 2.99B | 4.65B | 4.17B | 2.67B | 2.07B |
| Investing Cash Flow | 0.00 | -272.00M | -815.00M | -580.00M | -821.00M | -917.00M |
| Financing Cash Flow | 0.00 | -2.83B | -3.75B | -1.88B | -1.67B | -2.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥51.37B | 8.97 | ― | 5.04% | -6.31% | 6.66% | |
71 Outperform | ¥49.99B | 19.69 | ― | 5.17% | 0.82% | -5.38% | |
70 Outperform | ¥34.14B | 9.32 | ― | 3.76% | -3.84% | 16.27% | |
65 Neutral | ¥43.16B | 15.76 | ― | 2.97% | 1.99% | -3.72% | |
64 Neutral | ¥41.42B | 19.61 | ― | 2.53% | 1.74% | 41.32% | |
62 Neutral | ¥50.86B | 10.89 | ― | 0.52% | -1.79% | 27.43% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |